Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme

被引:74
作者
Ciatto, S. [1 ]
Martinelli, F. [1 ]
Castiglione, G. [1 ]
Mantellini, P. [1 ]
Rubeca, T. [1 ]
Grazzini, G. [1 ]
Bonanomi, A. G. [1 ]
Confortini, M. [1 ]
Zappa, M. [1 ]
机构
[1] Ctr Studio & Prevenz Oncol, I-50131 Florence, Italy
关键词
colorectal cancer; faecal occult blood testing; FOBT; screening;
D O I
10.1038/sj.bjc.6603534
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We assessed the correlation between quantitative results of immunological faecal occult blood testing (I-FOBT) and colonic lesions (191 colorectal cancers, 890 adenomas) detected at colonoscopy in 2597 FOBT + (cutoff 100 ng ml(-1) Hb) subjects. At univariate analysis, a higher average faecal Hb content was significantly associated with male gender (P = 0.003), age (P = 0.02), and colonoscopy findings (P = 0.000). Among adenomas, higher faecal Hb content was significantly associated with size (P = 0.0000), presence of severe dysplasia (P = 0.0001), presence of villous component (P = 0.0002), and location in the left colon (P = 0.003). At multivariate analysis adjusting for potential confounders, age (P = 0.03), size (P = 0.0000), and location in the left colon (P = 0.0005) were confirmed as having an independent association with higher faecal Hb content. Immunological FOBT is confirmed to be a specific screening test to detect cancer and adenoma, with a low positivity rate (3.7%) and a high positive predictive value (41.5%). Faecal Hb content is significantly higher for those lesions (cancer and high-risk adenomas) screening is aimed at detecting.
引用
收藏
页码:218 / 221
页数:4
相关论文
共 19 条
[1]  
Advisory Comm Canc Prevention, 2000, EUR J CANCER, V36, P1473
[2]   Reducing colorectal cancer mortality by repeated faecal occult blood test: a nested case-control study [J].
Bertario, L ;
Russo, A ;
Crosignani, P ;
Sala, P ;
Spinelli, P ;
Pizzetti, P ;
Andreola, S ;
Berrino, F .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (06) :973-977
[3]  
Castiglione G, 1997, J Med Screen, V4, P142
[4]   Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer [J].
Castiglione, G ;
Zappa, M ;
Grazzini, G ;
Mazzotta, A ;
Biagini, M ;
Salvadori, P ;
Ciatto, S .
BRITISH JOURNAL OF CANCER, 1996, 74 (01) :141-144
[5]   Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests [J].
Castiglione, G ;
Zappa, M ;
Grazzini, G ;
Rubeca, T ;
Turco, P ;
Sani, C ;
Ciatto, S .
JOURNAL OF MEDICAL SCREENING, 2000, 7 (01) :35-37
[6]   Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood [J].
Castiglione, G ;
Grazzini, G ;
Miccinesi, G ;
Rubeca, T ;
Sani, C ;
Turco, P ;
Zappa, M .
JOURNAL OF MEDICAL SCREENING, 2002, 9 (03) :99-103
[7]   Fecal occult blood screening in the Minnesota study: Role of chance detection of lesions [J].
Ederer, F ;
Church, TR ;
Mandel, JS .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (19) :1423-1428
[8]   Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value [J].
Edwards, JB .
PATHOLOGY, 2005, 37 (06) :565-U14
[9]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[10]   Randomised study of screening for colorectal cancer with faecal-occult-blood test [J].
Kronborg, O ;
Fenger, C ;
Olsen, J ;
Jorgensen, OD ;
Sondergaard, O .
LANCET, 1996, 348 (9040) :1467-1471